Add like
Add dislike
Add to saved papers

Ozone-UV-catalysis based advanced oxidation process for wastewater treatment.

A bench-scale advanced oxidation (AO) reactor was investigated for the degradation of six pollutants (2-naphthol, phenol, oxalic acid, phthalate, methylene blue, and D-glucose) in a model wastewater at with the aim to test opportunities for the further upscale to industrial applications. Six experimental conditions were designed to completely examine the experimental reactor, including photolysis, photocatalysis, ozonation, photolytic ozonation, catalytic ozonation, and photocatalytic ozonation. The stationary catalyst construction was made from commercially available TiO2 nanopowder by mounting it on a glass support and subsequently characterized for morphology (X-ray diffraction analysis and scanning electron microscopy) as well as durability. The ozone was generated in a dielectrical barrier discharge reactor using air as a source of oxygen. The degradation efficiency was estimated by the decrease in total organic carbon (TOC) concentration as well as toxicity using Daphnia magna, and degradation by-products by ultra-performance liquid chromatography-mass spectrometry. The photocatalytic ozonation was the most effective for the treatment of all model wastewater. The photocatalytic ozonation was most effective against ozonation and photolytic ozonation at tested pH values. A complete toxicity loss was obtained after the treatment using photocatalytic ozonation. The possible degradation pathway of the phthalate by oxidation was suggested based on aromatic ring opening reactions. The catalyst used at this experiment confirmed as a durable for continuous use with almost no loss of activity over time. The design of the reactor was found to be very effective for water treatment using photocatalytic ozonation. Such design has a high potential and can be further upscaled to industrial applications due to the simplicity and versatility of manufacturing and maintenance.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app